Delivery Order SPE2DR25D2014-SPE2DR26FA1Z5
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $28,361.43 to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count units) on January 7, 2026, with an ultimate completion date of January 29, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Voranigo 40 mg tablets (30-count packages) with a ceiling value of $54,189.90. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 19, 2025, with performance based at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was competed among qualified vendors in the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 26, 2025, for the supply of Voranigo 40 mg tablets (30-count) with a ceiling value of $28,553.91. This firm fixed-price delivery order is scheduled for completion by January 20, 2026, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Voranigo 40 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $81,284.85 and an ultimate completion date of August 29, 2025. The contract is not set-aside and represents a competitive award to the prime contractor. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $28,553.91 to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count units) on December 15, 2025, with completion expected by January 7, 2026. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a potential value of $999,999,999.00 and extends through December...
- The Defense Logistics Agency awarded a $113,445.72 delivery order to AmerisourceBergen Drug Corp on January 2, 2026, for the supply of Voranigo 40 mg tablets (30-count units) with a completion date of January 26, 2026. This competitively awarded, firm fixed-price contract is non-set-aside and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA...
- The Defense Logistics Agency awarded a $27,094.95 delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Voranigo 40 mg tablets (30-count units). This firm fixed-price contract, designated as a non-competitive, non-set-aside award, is scheduled for completion by November 28, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's extensive...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for supply of Voranigo 40 mg tablets (30-count packages) with a ceiling value of $27,094.95. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of October 16, 2025. The award represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with the federal...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Voranigo 40 mg tablets in a quantity of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $54,189.90 and employs firm fixed pricing, with an ultimate completion date of September 16, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and...
- The Defense Logistics Agency awarded a $28,553.91 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count units) on December 16, 2025, with an ultimate completion date of January 8, 2026. This non-set-aside competitive award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The place of...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FA1Z5Delivery Order
This delivery order, awarded on January 9, 2026, by the Defense Logistics Agency to AmerisourceBergen Drug Corp, provides for the supply of Voranigo 40 mg tablets in a quantity of 30 units with a ceiling value of $28,361.43. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of February 2, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was used in this competitive award. This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at up to $999,999,999 and extending through December 2026. The parent company, Cencora, Inc. (doing business as AmerisourceBergen), holds a substantial IDC with the DLA valued up to $999,999,999 through December 31, 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen functions as a critical pharmaceutical distributor for federal medical procurement, supplying brand-name and generic medications across multiple therapeutic domains to military treatment facilities and other federal health systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $28.4k | 1/8/26 |